147 related articles for article (PubMed ID: 34142813)
21. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy.
Yu J; Zhang X; Pei Z; Shuai Q
J Mater Chem B; 2021 Nov; 9(44):9142-9152. PubMed ID: 34693960
[TBL] [Abstract][Full Text] [Related]
22. Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy.
Wang K; Xiao X; Liu Y; Zong Q; Tu Y; Yuan Y
Biomaterials; 2022 Oct; 289():121803. PubMed ID: 36150300
[TBL] [Abstract][Full Text] [Related]
23. Prodrug-embedded angiogenic vessel-targeting nanoparticle: A positive feedback amplifier in hypoxia-induced chemo-photo therapy.
Guo D; Xu S; Wang N; Jiang H; Huang Y; Jin X; Xue B; Zhang C; Zhu X
Biomaterials; 2017 Nov; 144():188-198. PubMed ID: 28837960
[TBL] [Abstract][Full Text] [Related]
24. Mussel-Derived, Cancer-Targeting Peptide as pH-Sensitive Prodrug Nanocarrier.
Ma Y; He P; Tian X; Liu G; Zeng X; Pan G
ACS Appl Mater Interfaces; 2019 Jul; 11(27):23948-23956. PubMed ID: 31192575
[TBL] [Abstract][Full Text] [Related]
25. ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer.
Ma J; Chen Y; Liang W; Li L; Du J; Pan C; Zhang C
Drug Deliv; 2021 Dec; 28(1):1204-1213. PubMed ID: 34142633
[TBL] [Abstract][Full Text] [Related]
26. Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers.
Liu Y; Zhang H; Cui H; Zhang F; Zhao L; Liu Y; Meng Q
Drug Deliv; 2022 Dec; 29(1):342-350. PubMed ID: 35049388
[TBL] [Abstract][Full Text] [Related]
27. Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy.
Sun CY; Zhang BB; Zhou JY
J Mater Chem B; 2019 Aug; 7(31):4843-4853. PubMed ID: 31389968
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
[TBL] [Abstract][Full Text] [Related]
29. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
[TBL] [Abstract][Full Text] [Related]
30. Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy.
Lee S; Lee Y; Kim H; Lee DY; Jon S
Biomacromolecules; 2018 Jun; 19(6):2270-2277. PubMed ID: 29712433
[TBL] [Abstract][Full Text] [Related]
31. Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery.
Leong J; Chin W; Ke X; Gao S; Kong H; Hedrick JL; Yang YY
Nanomedicine; 2018 Nov; 14(8):2666-2677. PubMed ID: 30017961
[TBL] [Abstract][Full Text] [Related]
32. Tumor Homing Reactive Oxygen Species Nanoparticle for Enhanced Cancer Therapy.
Cho HY; Mavi A; Chueng SD; Pongkulapa T; Pasquale N; Rabie H; Han J; Kim JH; Kim TH; Choi JW; Lee KB
ACS Appl Mater Interfaces; 2019 Jul; 11(27):23909-23918. PubMed ID: 31252451
[TBL] [Abstract][Full Text] [Related]
33. Assembly of polymer micelles through the sol-gel transition for effective cancer therapy.
Khaliq NU; Oh KS; Sandra FC; Joo Y; Lee J; Byun Y; Kim IS; Kwon IC; Seo JH; Kim SY; Yuk SH
J Control Release; 2017 Jun; 255():258-269. PubMed ID: 28456679
[TBL] [Abstract][Full Text] [Related]
34. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
35. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
[TBL] [Abstract][Full Text] [Related]
36. A tumor microenvironment responsive nanosystem for chemodynamic/chemical synergistic theranostics of colorectal cancer.
Wang L; Xia J; Fan H; Hou M; Wang H; Wang X; Zhang K; Cao L; Liu X; Ling J; Yu H; Wu X; Sun J
Theranostics; 2021; 11(18):8909-8925. PubMed ID: 34522218
[No Abstract] [Full Text] [Related]
37. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
38. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
Kwon S; Ko H; You DG; Kataoka K; Park JH
Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
[TBL] [Abstract][Full Text] [Related]
39. Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy.
Bertucci A; Kim KH; Kang J; Zuidema JM; Lee SH; Kwon EJ; Kim D; Howell SB; Ricci F; Ruoslahti E; Jang HJ; Sailor MJ
ACS Appl Mater Interfaces; 2019 Jul; 11(27):23926-23937. PubMed ID: 31251556
[TBL] [Abstract][Full Text] [Related]
40. Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy.
Luo C; Sun B; Wang C; Zhang X; Chen Y; Chen Q; Yu H; Zhao H; Sun M; Li Z; Zhang H; Kan Q; Wang Y; He Z; Sun J
J Control Release; 2019 May; 302():79-89. PubMed ID: 30946853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
